ARCHIVES

Blood Vessel Growth Inhibitor May Be Tested Against KS

This article is from The Cancer Letter archive.

Vol. 17 No. 33 | August 16, 1991

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

American cancer Society Funds 84 Research Grants. NCI, NIGMS To Support Synchrotron Beamlines.

November 16, 2001

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010

New Data Support Claims That Costs Are Higher For Protocol Patients

August 31, 1984

ASRO President Tells Colleagues To Take Charge

October 26, 1990